A re-examination of the use of ethnicity in prenatal carrier testing.

摘要: In April 2011, the American Congress of Obstetricians and Gynecologists (formerly College Obstetrics Gynecology [ACOG]), updated its policy on carrier screening for cystic fibrosis proposed that because increasing difficulty in assigning a single ethnicity to individuals, “It is reasonable, therefore offer CF all patients.” However, ACOG continues use guidelines about testing autosomal recessive disorders like sickle cell disease (SCD) Tay-Sachs (TSD). This practice marked contrast with newborn (NBS) which universally provided conditions. this manuscript, I evaluate discrepant role NBS screening. argue needs adopt position it now takes regarding prenatal To promote equity decision making, health care policies must acknowledge diversity populations we serve empower women couples make more fully informed reproductive decisions by offering all. © 2011 Wiley Periodicals, Inc.